Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Olson

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Gastroenterology|July 15, 2009
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximabWilliam J Sandborn, Paul Rutgeerts, Brian G Feagan, et al.
Alimentary Pharmacology & Therapeutics|January 11, 2022
Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitisSilvio Danese, Barrett G Levesque, Brian G Feagan, et al.
Alimentary Pharmacology & Therapeutics|March 4, 2022
Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Authors' replySilvio Danese, Barrett G Levesque, Brian G Feagan, et al.
Gut|August 5, 2018
Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trialVipul Jairath, Laurent Peyrin-Biroulet, Guangyong Zou, et al.
European Journal of Heart Failure|March 9, 2013
Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fractionMihai Gheorghiade, Stephen J Greene, Piotr Ponikowski, et al.
Gastroenterology|November 6, 2018
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic EsophagitisIkuo Hirano, Margaret H Collins, Yehudith Assouline-Dayan, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Gastroenterology|July 15, 2009
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximabWilliam J Sandborn, Paul Rutgeerts, Brian G Feagan, et al.
Alimentary Pharmacology & Therapeutics|January 11, 2022
Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitisSilvio Danese, Barrett G Levesque, Brian G Feagan, et al.
Alimentary Pharmacology & Therapeutics|March 4, 2022
Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Authors' replySilvio Danese, Barrett G Levesque, Brian G Feagan, et al.
Gut|August 5, 2018
Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trialVipul Jairath, Laurent Peyrin-Biroulet, Guangyong Zou, et al.
European Journal of Heart Failure|March 9, 2013
Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fractionMihai Gheorghiade, Stephen J Greene, Piotr Ponikowski, et al.
Gastroenterology|November 6, 2018
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic EsophagitisIkuo Hirano, Margaret H Collins, Yehudith Assouline-Dayan, et al.
Pageof 3